Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Universal Ibogaine Inc V.IBO

Alternate Symbol(s):  IBOGF

Universal Ibogaine Inc. is a Canada-based life sciences company. The Company is transforming addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorders. The Company is engaged in developing a holistic addiction treatment protocol at its Kelburn Recovery Center (located near Winnipeg, Manitoba), which paired with the planned ibogaine detox protocol, is intended to treat addiction and improve the lives of individuals and families affected by addiction. Ibogaine is a naturally occurring molecule derived from the root bark of the iboga tree and other plants. It is a potent and serious medical psychedelic which has addiction interrupting properties. Ibogaine targets multiple receptors across multiple sites in the brain and metabolizes into noribogaine, a serotonin re-uptake inhibitor that remains in the body for 1-4 months, associated with elimination of addictive cravings.


TSXV:IBO - Post by User

Post by yukon_goldon Oct 02, 2021 9:39pm
316 Views
Post# 33958139

Universal Ibogaine TSXV Final Approval & Trading Resumes

Universal Ibogaine TSXV Final Approval & Trading Resumes
image
 

TSX FINAL APPROVAL

Universal Ibogaine Announces TSXV Final Approval of QT, Resumption of Trading and Clarification of Certain Filing Statement Disclosures

Dear Investors,

To our valued Shareholders, Stakeholders and Community:

We are pleased to advise that we have received the TSX Final Exchange Bulletin approving the Qualifying Transaction and public trading.

Listing and trading of UI shares on the TSXV under symbol IBO will thus commence at the opening on Tuesday October 5, 2021.

Read the full Press Release here.

We would like to thank you all for your continued support in this process. We exist to support our community and to provide solutions to the universal challenge of addiction. Your endless support is our fuel.

Please stay posted for further updates to come.

Dr. Rami Batal
CEO

For any questions, please contact us through info@universalibogaine.com

 

Please let us know if you have have any questions or feedback, we love hearing from our community, we could not do this without you!

Profile Image Universal Ibogaine
Info@UniversalIbogaine.com
1 (855) IBOGAINE - (426-4246)
UniversalIbogaine.com
 
 
Facebook Twitter LinkedIn YouTube

 

Universal Ibogaine Inc. 595 Howe Street Suite 303 Vancouver, British Columbia V6C2T5 Canada 1 (855) 426-4246


<< Previous
Bullboard Posts
Next >>